Paper8912499
Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors?
Firestein GS. Arthritis Rheum, 1996. Cited by 523 papers, by iCite.
Cite this record
ConductScience Library. Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors? Papers, record 8912499. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8912499
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors?
- PubMed
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Arthritis, Rheumatoid | Major topic |
| Fibroblasts | Major topic |
| Synovial Membrane | Major topic |
| Humans |
Source PubMed
Cited by185
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 523 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41795104 | Soluble factors released from fibroblast-like synoviocytes of JIA patients with future extended course can condition persistent JIA synovial fibroblasts for increased IL-6 production. | Arthritis Res Ther | 2026 | https://conductscience.org/library/papers/41795104 | PubMed |
| 41137999 | Function of p53 in angiogenesis and oxidative stress in rheumatoid arthritis. | Clin Exp Med | 2025 | https://conductscience.org/library/papers/41137999 | PubMed |
| 40798883 | Galectin-9 inhibition of the MIF-CD74/CD44 pathway suppresses chronic arthritis. | Mol Ther | 2025 | https://conductscience.org/library/papers/40798883 | PubMed |
| 40591034 | Deciphering the role of ERK and PI3K/Akt as crosstalk pathways between fibroblast-like synoviocytes and osteoclasts; novel therapeutic approach for rheumatoid arthritis. | Mol Biol Rep | 2025 | https://conductscience.org/library/papers/40591034 | PubMed |
| 38895122 | Fibrotic pathways and fibroblast-like synoviocyte phenotypes in osteoarthritis. | Front Immunol | 2024 | https://conductscience.org/library/papers/38895122 | PubMed |
| 37946278 | Rspo2 exacerbates rheumatoid arthritis by targeting aggressive phenotype of fibroblast-like synoviocytes and disrupting chondrocyte homeostasis via Wnt/β-catenin pathway. | Arthritis Res Ther | 2023 | https://conductscience.org/library/papers/37946278 | PubMed |
| 37714911 | IL-1β stimulated human umbilical cord mesenchymal stem cells ameliorate rheumatoid arthritis via inducing apoptosis of fibroblast-like synoviocytes. | Sci Rep | 2023 | https://conductscience.org/library/papers/37714911 | PubMed |
| 37605002 | Fibroblast multiplicity in RA: a synovial state of affairs. | Nat Rev Rheumatol | 2023 | https://conductscience.org/library/papers/37605002 | PubMed |
| 37567983 | Causal inference between rheumatoid arthritis and prostate cancer. | Clin Exp Med | 2023 | https://conductscience.org/library/papers/37567983 | PubMed |
| 37298499 | Inflammatory Mesenchymal Stem Cells Express Abundant Membrane-Bound and Soluble Forms of C-Type Lectin-like CD248. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37298499 | PubMed |
| 37202190 | [Berberine inhibits autophagy and promotes apoptosis of fibroblast-like synovial cells from rheumatoid arthritis patients through the ROS/mTOR signaling pathway]. | Nan Fang Yi Ke Da Xue Xue Bao | 2023 | https://conductscience.org/library/papers/37202190 | PubMed |
| 36167601 | Single-cell analysis reveals heterogeneity of juvenile idiopathic arthritis fibroblast-like synoviocytes with implications for disease subtype. | Arthritis Res Ther | 2022 | https://conductscience.org/library/papers/36167601 | PubMed |
| 35874765 | Recent Insights Into the Role of Macrophages in Acute Gout. | Front Immunol | 2022 | https://conductscience.org/library/papers/35874765 | PubMed |
| 35712709 | Hyaluronic Acid Hydrogels Hybridized With Au-Triptolide Nanoparticles for Intraarticular Targeted Multi-Therapy of Rheumatoid Arthritis. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/35712709 | PubMed |
| 35265082 | New Druggable Targets for Rheumatoid Arthritis Based on Insights From Synovial Biology. | Front Immunol | 2022 | https://conductscience.org/library/papers/35265082 | PubMed |
| 35148758 | Methotrexate-loaded nanoparticles ameliorate experimental model of autoimmune arthritis by regulating the balance of interleukin-17-producing T cells and regulatory T cells. | J Transl Med | 2022 | https://conductscience.org/library/papers/35148758 | PubMed |
| 35117656 | Neurological paraneoplastic syndrome caused by small cell lung cancer: a case report. | Transl Cancer Res | 2020 | https://conductscience.org/library/papers/35117656 | PubMed |
| 35008549 | 14-3-3η Promotes Invadosome Formation via the FOXO3-Snail Axis in Rheumatoid Arthritis Fibroblast-like Synoviocytes. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/35008549 | PubMed |
| 34603528 | Quercetin suppresses inflammatory cytokine production in rheumatoid arthritis fibroblast-like synoviocytes. | Exp Ther Med | 2021 | https://conductscience.org/library/papers/34603528 | PubMed |
| 33983569 | The p53 status in rheumatoid arthritis with focus on fibroblast-like synoviocytes. | Immunol Res | 2021 | https://conductscience.org/library/papers/33983569 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8912499
GET https://conductscience.org/api/papers/v1/8912499/cited_by?page=2